Death Receptor 6 is Epigenetically Silenced by Histone Deacetylation in Endometriosis and Promotes the Pathogenesis of Endometriosis

Kentaro Kai, Kaei Nasu, Nasu K, Kawano Y, Yukie Kawano, Aoyagi Y, Yoko Aoyagi, Yoshiyuki Tsukamoto, Tsukamoto Y, Hijiya N, Naoki Hijiya, Abe W, Wakana Abe, Okamoto M, Mamiko Okamoto, Moriyama M, Masatsugu Moriyama, Hisashi Narahara, Narahara H
American journal of reproductive immunology (New York, N.Y. : 1989) · 2013 · vol. 70(6) , pp. 485–496 · doi:10.1111/aji.12155 · PMID:24028773 · W1989121271
article OA: closed CC0 ⤵ 12 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Death receptor 6 is epigenetically silenced by histone deacetylation in endometriosis, promoting cell proliferation and resistance to apoptosis in this condition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

PROBLEM: The purpose of this study is to evaluate the involvement of death receptor (DR) 6 in the pathogenesis of endometriosis. METHODS OF STUDY: Endometriotic cyst stromal cells (ECSCs) and normal endometrial stromal cells (NESCs) were isolated from ovarian endometriotic tissues and the eutopic endometrial tissues, respectively. The effect of valproic acid (VPA) on the DR6 expression in ECSCs was examined. The roles of DR6 in NESC proliferation and apoptosis were investigated with DR6 siRNA transfection. The distribution of DR6 protein in ovarian endometriotic tissues and normal proliferative-phase endometrium was examined by immunohistochemistry. The expression of DR6 mRNA and protein in ECSCs and NESCs was also examined. RESULTS: Death receptor 6 expression was attenuated in ECSCs and in endometriotic tissues, and its expression was upregulated by VPA stimulation. VPA treatment resulted in an accumulation of acetylated histone H4 in the promoter region of the DR6 gene. DR6 knockdown directed the stimulation of cell proliferation and the resistance to apoptosis in NESCs. CONCLUSION: The present findings suggested that DR6 is involved in the pathogenesis of endometriosis by creating the proliferative and anti-apoptotic characteristics of endometriosis. The results also suggest that histone deacetylase inhibitors are promising agents for the treatment of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Gene Silencing Histones Histones Receptors, Tumor Necrosis Factor Acetylation Adult Endometriosis Endometriosis Female Histones Humans Receptors, Tumor Necrosis Factor RNA, Messenger RNA, Messenger Stromal Cells Stromal Cells Stromal Cells

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (43)

Cited by (12)

SciLite annotations

chemicals 2
histone valproic acid

Source provenance

europepmc
last seen: 2026-09-02T06:13:17.951775+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:53.335890+00:00
scilite
last seen: 2026-05-18T04:25:29.313245+00:00
unpaywall
last seen: 2026-09-01T06:29:04.589233+00:00
License: CC0 · commercial use OK